Back
Apellis Pharmaceuticals Stock Price Chart
Pacaso, now reserving Nasdaq ticker PCSO, is offering shares at $2.80 until May 29.
This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com.*Pacaso recently received their ticker reservation with Nasdaq
Sell
34
APLS
Apellis Pharmaceuticals
Last Price:
$17.45
Seasonality Move:
2.29%
7 Day Trial
ALL ACCESS PASS
$
7
Is the Traditional House Obsolete?
Disclosure: *This is a paid advertisement for Boxabl's Regulation A offering. Please read the offering circular at invest.boxabl.com. This is a message from Boxabl.-
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and APLS is experiencing slight buying pressure.
Apellis Pharmaceuticals Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 17.42 | Buy |
| 20-day SMA: | 18.11 | Sell |
| 50-day SMA: | 19.97 | Sell |
| 200-day SMA: | 28.53 | Sell |
| 8-day EMA: | 17.62 | Sell |
| 20-day EMA: | 18.04 | Sell |
| 50-day EMA: | 20.09 | Sell |
| 200-day EMA: | 28.66 | Sell |
Apellis Pharmaceuticals Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.67 | Sell |
| Relative Strength Index (14 RSI): | 42.89 | Sell |
| Chaikin Money Flow: | 20534 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (17.01 - 18.99) | Sell |
| Bollinger Bands (100): | (19.23 - 29.65) | Sell |
Apellis Pharmaceuticals Technical Analysis
| May 12 | May 13 | May 14 | May 15 | May 16 | May 19 | May 20 | May 21 | May 22 | May 23 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 12 | 13 | 14 | 15 | 16 | 19 | 20 | 21 | 22 | 23 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Apellis Pharmaceuticals Stock
Is Apellis Pharmaceuticals Stock a Buy?
-
Apellis Pharmaceuticals share price is 17.44 while APLS 8-day simple moving average is 17.42, which is a Buy signal.
-
The stock price of APLS is 17.44 while Apellis Pharmaceuticals 20-day SMA is 18.11, which makes it a Sell.
-
Apellis Pharmaceuticals 50-day simple moving average is 19.97 while APLS share price is 17.44, making it a Sell technically.
-
APLS stock price is 17.44 and Apellis Pharmaceuticals 200-day simple moving average is 28.53, creating a Sell signal.
APLS Technical Analysis vs Fundamental Analysis
Sell
34
Apellis Pharmaceuticals (APLS)
is a Sell
Is Apellis Pharmaceuticals a Buy or a Sell?
-
Apellis Pharmaceuticals stock is rated a SellThe current Apellis Pharmaceuticals [APLS] share price is $17.44. The Score for APLS is 34, which is 32% below its historic median score of 50, and infers higher risk than normal.
Apellis Pharmaceuticals Stock Info
Market Cap:
2.2B
Price in USD:
17.44
Share Volume:
1.3M
Apellis Pharmaceuticals 52-Week Range
52-Week High:
43.76
52-Week Low:
16.10
Sell
34
Apellis Pharmaceuticals (APLS)
is a Sell
Apellis Pharmaceuticals Share Price Forecast
-
What is the Apellis Pharmaceuticals stock price today?The Apellis Pharmaceuticals stock price is 17.44 USD today.
-
Will APLS stock go up or go down?Apellis Pharmaceuticals> share price is forecast to RISE/FALL based on technical indicators
-
Is Apellis Pharmaceuticals overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Apellis Pharmaceuticals is overvalued.
Is Apellis Pharmaceuticals Stock a Buy?
-
Apellis Pharmaceuticals share price is 17.44 while APLS 8-day exponential moving average is 17.62, which is a Sell signal.
-
The stock price of APLS is 17.44 while Apellis Pharmaceuticals 20-day EMA is 18.04, which makes it a Sell.
-
Apellis Pharmaceuticals 50-day exponential moving average is 20.09 while APLS share price is 17.44, making it a Sell technically.
-
APLS stock price is 17.44 and Apellis Pharmaceuticals 200-day simple moving average is 28.66, creating a Sell signal.
Fundamental Analysis of Apellis Pharmaceuticals
Is Apellis Pharmaceuticals a good investment?
-
Analysts estimate an earnings decrease this quarter of $0.12 per share, an increase next quarter of $0.19 per share, a decrease this year of $0.19 per share, and an increase next year of $1.21 per share.
Technical Analysis of Apellis Pharmaceuticals
Should I short Apellis Pharmaceuticals stock?
-
APLS Moving Average Covergence Divergence (MACD) indicator is -0.67, suggesting Apellis Pharmaceuticals is a Sell
-
Apellis Pharmaceuticals Relative Strength Index (RSI) is 42.89, which suggest Apellis Pharmaceuticals is oversold
-
The Bollinger Bands (25) for Apellis Pharmaceuticals is (17.01 - 18.99), which suggest Apellis Pharmaceuticals is a Sell
-
The Bollinger Bands (100) for Apellis Pharmaceuticals is (19.23 - 29.65), which suggest Apellis Pharmaceuticals is a Sell
* Apellis Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.